CORAL LABORATORIES LTD.

Coral Laboratories Ltd has responded to a query from the BSE regarding a significant movement in its stock price. The company stated that the price fluctuation is purely market-driven and not influenced by any specific company news or insider knowledge. Management confirmed they have no control or awareness of the reasons behind the price movement. Coral Laboratories assured the BSE that it continues to comply with all disclosure obligations under SEBI regulations.

Coral Laboratories Ltd has announced the closure of its trading window for all designated persons and their relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 1, 2026, until 48 hours after the declaration of the unaudited standalone financial results for the quarter ending June 30, 2026. The company will separately announce the date of the board meeting to consider these financial results.

Coral Laboratories Ltd announced the outcome of its board meeting held on June 18, 2026. The board approved a proposal to increase the remuneration of Ms. Meera Doshi, who holds an office or place of profit within the company. Additionally, the board approved the issuance of a Postal Ballot Notice to seek shareholder approval for this and potentially other matters. The meeting was brief, lasting from 11:45 a.m. to 12:30 p.m.

Coral Laboratories Ltd announced the outcome of its board meeting held on June 18, 2026. The board approved a proposal to increase the remuneration of Ms. Meera Doshi, who holds an office or place of profit within the company. Additionally, the board approved the issuance of a Postal Ballot Notice to seek shareholder approval for this decision. The meeting was conducted from 11:45 a.m. to 12:30 p.m.

Coral Laboratories Ltd's Board of Directors, in their meeting held on May 30, 2026, recommended a final dividend of 20%, which is ₹2.00 per share with a face value of ₹10 each for the financial year 2025-26. The dividend is subject to the approval of the members at the upcoming Annual General Meeting.

Coral Laboratories Ltd. has appointed M/s. S K Doshi & Associates, Chartered Accountants, as its Internal Auditors for the financial year 2026-2027, effective from May 30, 2026. The appointment follows the recommendation of the Audit Committee and approval by the Board of Directors. M/s S K Doshi & Associates was established in 1986 and provides professional services with expertise in internal audit, accounts, audit, taxation, and related services. The internal auditor is not related to any directors of the company.

Coral Laboratories Ltd has appointed M/s Aatish Dhatrak & Associates as the Cost Auditors for the financial year 2026-2027, effective from May 30, 2026. The appointment follows the recommendation of the Audit Committee and approval by the Board of Directors. Aatish Dhatrak & Associates is a partnership firm of Cost Accountants with expertise in cost audit, accounts, audit, risk management, and project management. There are no relationships between the Cost Auditor and any Directors of the company.

Coral Laboratories Ltd's board meeting on May 30, 2026, approved the audited financial results for the quarter and financial year ended March 31, 2026. The board recommended a final dividend of 20% i.e. ₹ 2.00 per share with face value of ₹ 10/- each for FY26, subject to shareholder approval. M/s. S K Doshi & Associates were appointed as Internal Auditor and M/s Aatish Dhatrak & Associates as Cost Auditor for FY27.

Coral Laboratories Ltd's board approved the audited financial results for the year ended March 31, 2026. The company reported revenue from operations of ₹8589.97 lakhs and a profit for the period of ₹1638.13 lakhs. The board has recommended a final dividend of 20% (₹2.00 per share) for the financial year 2025-2026, subject to shareholder approval. Additionally, M/s. S K Doshi & Associates and M/s Aatish Dhatrak & Associates were appointed as Internal Auditor and Cost Auditor, respectively, for the financial year 2026-2027.

Coral Laboratories Ltd's board has approved a final dividend of ₹2 per share (20% on face value of ₹10) for the financial year 2025-2026, subject to shareholder approval at the Annual General Meeting. The board also approved the audited financial results for the quarter and financial year ended March 31, 2026. Additionally, M/s. S K Doshi & Associates, Chartered Accountants, were appointed as Internal Auditor, and M/s Aatish Dhatrak & Associates, Cost Accountants, were appointed as Cost Auditor for the financial year 2026-2027.